Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Michel Lecendreux"'
Autor:
Hanna M. Ollila, Eilon Sharon, Ling Lin, Nasa Sinnott-Armstrong, Aditya Ambati, Selina M. Yogeshwar, Ryan P. Hillary, Otto Jolanki, Juliette Faraco, Mali Einen, Guo Luo, Jing Zhang, Fang Han, Han Yan, Xiao Song Dong, Jing Li, Jun Zhang, Seung-Chul Hong, Tae Won Kim, Yves Dauvilliers, Lucie Barateau, Gert Jan Lammers, Rolf Fronczek, Geert Mayer, Joan Santamaria, Isabelle Arnulf, Stine Knudsen-Heier, May Kristin Lyamouri Bredahl, Per Medbøe Thorsby, Giuseppe Plazzi, Fabio Pizza, Monica Moresco, Catherine Crowe, Stephen K. Van den Eeden, Michel Lecendreux, Patrice Bourgin, Takashi Kanbayashi, Francisco J. Martínez-Orozco, Rosa Peraita-Adrados, Antonio Benetó, Jacques Montplaisir, Alex Desautels, Yu-Shu Huang, FinnGen, Poul Jennum, Sona Nevsimalova, David Kemlink, Alex Iranzo, Sebastiaan Overeem, Aleksandra Wierzbicka, Peter Geisler, Karel Sonka, Makoto Honda, Birgit Högl, Ambra Stefani, Fernando Morgadinho Coelho, Vilma Mantovani, Eva Feketeova, Mia Wadelius, Niclas Eriksson, Hans Smedje, Pär Hallberg, Per Egil Hesla, David Rye, Zerrin Pelin, Luigi Ferini-Strambi, Claudio L. Bassetti, Johannes Mathis, Ramin Khatami, Adi Aran, Sheela Nampoothiri, Tomas Olsson, Ingrid Kockum, Markku Partinen, Markus Perola, Birgitte R. Kornum, Sina Rueger, Juliane Winkelmann, Taku Miyagawa, Hiromi Toyoda, Seik-Soon Khor, Mihoko Shimada, Katsushi Tokunaga, Manuel Rivas, Jonathan K. Pritchard, Neil Risch, Zoltan Kutalik, Ruth O’Hara, Joachim Hallmayer, Chun Jimmie Ye, Emmanuel J. Mignot
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors include pandemic 2009 H1N1 influenza A infection and immunization with Pandemrix®. Here, we dissect disease mechanisms and interactions with environ
Externí odkaz:
https://doaj.org/article/5ce5735744474cff8886bce42fe536b9
Autor:
Gianina Luca, Mojtaba Bandarabadi, Eric Konofal, Michel Lecendreux, Laurent Ferrié, Bruno Figadère, Mehdi Tafti
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Psychostimulants are used for the treatment of excessive daytime sleepiness in a wide range of sleep disorders as well as in attention deficit hyperactivity disorder or cognitive impairment in neuropsychiatric disorders. Here, we tested in mice the w
Externí odkaz:
https://doaj.org/article/0957d083a93349bf8d3c58c815b43996
Autor:
Michel Lecendreux, Guillaume Churlaud, Fabien Pitoiset, Armelle Regnault, Tu Anh Tran, Roland Liblau, David Klatzmann, Michelle Rosenzwajg
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169836 (2017)
Narcolepsy is a rare neurologic disorder characterized by excessive daytime sleepiness, cataplexy and disturbed nocturnal sleep patterns. Narcolepsy type 1 (NT1) has been shown to result from a selective loss of hypothalamic hypocretin-secreting neur
Externí odkaz:
https://doaj.org/article/c0746eafbbd9469dba7c55d3e1823dd5
Autor:
Juliette Faraco, Ling Lin, Birgitte Rahbek Kornum, Eimear E Kenny, Gosia Trynka, Mali Einen, Tom J Rico, Peter Lichtner, Yves Dauvilliers, Isabelle Arnulf, Michel Lecendreux, Sirous Javidi, Peter Geisler, Geert Mayer, Fabio Pizza, Francesca Poli, Giuseppe Plazzi, Sebastiaan Overeem, Gert Jan Lammers, David Kemlink, Karel Sonka, Sona Nevsimalova, Guy Rouleau, Alex Desautels, Jacques Montplaisir, Birgit Frauscher, Laura Ehrmann, Birgit Högl, Poul Jennum, Patrice Bourgin, Rosa Peraita-Adrados, Alex Iranzo, Claudio Bassetti, Wei-Min Chen, Patrick Concannon, Susan D Thompson, Vincent Damotte, Bertrand Fontaine, Maxime Breban, Christian Gieger, Norman Klopp, Panos Deloukas, Cisca Wijmenga, Joachim Hallmayer, Suna Onengut-Gumuscu, Stephen S Rich, Juliane Winkelmann, Emmanuel Mignot
Publikováno v:
PLoS Genetics, Vol 9, Iss 2, p e1003270 (2013)
Recent advances in the identification of susceptibility genes and environmental exposures provide broad support for a post-infectious autoimmune basis for narcolepsy/hypocretin (orexin) deficiency. We genotyped loci associated with other autoimmune a
Externí odkaz:
https://doaj.org/article/3ca91a88c9be488cb1b4d498c130f020
Autor:
Yves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, Patricia Franco, Mikhail Poluektov, Christian Caussé, Isabelle Lecomte, Jeanne Marie Lecomte, Philippe Lehert, Jean Charles Schwartz, Giuseppe Plazzi
Publikováno v:
The Lancet Neurology. 22:303-311
Autor:
Annika Triller, Fabio Pizza, Michel Lecendreux, Lea Lieberich, Rana Rezaei, Anna Pech de Laclause, Stefano Vandi, Giuseppe Plazzi, Ulf Kallweit
Publikováno v:
Sleep Medicine. 103:62-68
Publikováno v:
Current Medicinal Chemistry. 30
Background: NLS-3 or (R, R) enantiomer of phacetoperane (levophacetoperane) is the reverse ester of methylphenidate, a well-documented psychostimulant marketed for the treatment of attention-deficit/hyperactivity disorder (ADHD) since the end of 1950
Autor:
Anna, Pech de Laclause, Christine, Gétin, Éric, Konofal, Samuele, Cortese, Michel, Lecendreux
ObjectiveOur objective is to explore the change in the severity of ADHD, ODD and anxiety during a two-month lockdown among children in France and the moderating role of behavioural regulation.MethodIn 235 children with ADHD, the symptom severity of A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45b8a71316480ae95642f9170e15c3d6
https://eprints.soton.ac.uk/454494/
https://eprints.soton.ac.uk/454494/
Autor:
Xavier Drouot, B. Faroux, Frédéric Gagnadoux, S. Hartley, Damien Leger, C. Charley-Monaca, Marie-Françoise Vecchierini, C. Philippe, Pierre Escourrou, Michel Lecendreux, Francis Martin, H. Trang, Patricia Franco
Publikováno v:
Médecine du Sommeil. 18:104-108
Resume La Societe francaise de recherche et medecine du sommeil (SFRMS) est responsable du processus d’accreditation des Centres du sommeil en France depuis 1994. L’objectif de l’accreditation est la reconnaissance et la mise en valeur d’une
Autor:
Michel Lecendreux, Sofiene Chenini, Lucie Barateau, Anna Laura Rassu, Régis Lopez, Isabelle Jaussent, Yves Dauvilliers, Séverine Béziat, Carole Pesenti
Publikováno v:
Neurology. 97:e476-e488
ObjectiveWe validated the Narcolepsy Severity Scale (NSS) in adults with narcolepsy type 1 (NT1) to quantify the severity, frequency, and consequences of the 5 key narcolepsy symptoms over the last month, and we now developed the Pediatric NSS (NSS-P